Table II.

 Number of Events and Person‐Time at Risk for Each Outcome, Stratified by Treatment Group and Age and Sex Subgroups

Outcome	ARB			ACE Inhibitor
	Events, No.	Person‐Years at Risk	Incidence Ratea	Events, No.	Person‐Years at Risk	Incidence Rate
Mortality	220	11,530	1.9	219	11,439	1.9
Age 50–65	29	3283	0.9	26	3402	0.8
Age 65+	182	7065	2.6	189	6884	2.8
Male	116	7140	1.6	116	7340	1.6
Female	104	4390	2.4	103	4099	2.5
CAD	141	9289	1.5	150	9309	1.6
Age 50–65	35	2939	1.2	26	3033	0.9
Age 65+	106	5330	2.0	119	5164	2.3
Male	81	5986	1.4	84	6348	1.3
Female	60	3303	1.8	66	2961	2.2
CKD	150	10,485	1.4	132	10,534	1.3
Age 50–65	20	3094	0.6	8	3279	0.2
Age 65+	127	6270	2.0	120	6152	2.0
Male	89	6420	1.4	81	6728	1.2
Female	61	4065	1.5	51	3806	1.3
Diabetes	220	8223	2.7	182	8044	2.3
Age 50–65	57	2445	2.3	61	2384	2.6
Age 65+	136	4826	2.8	102	4735	2.2
Male	136	5184	2.6	115	5265	2.2
Female	84	3039	2.8	67	2779	2.4
Stroke	94	11,066	0.8	87	11,047	0.8
Age 50–65	10	3226	0.3	9	3368	0.3
Age 65+	83	6652	1.2	77	6527	1.2
Male	61	6839	0.9	52	7090	0.7
Female	33	4227	0.8	35	3957	0.9

Abbreviations: ACE, angiotensin‐converting enzyme; ARB, angiotensin receptor blocker; CAD, coronary artery disease; CKD, chronic kidney disease. ^aIncidence rate is number of events per 100 person‐years.